124 related articles for article (PubMed ID: 26359300)
1. EGF augments TGFβ-induced epithelial-mesenchymal transition by promoting SHP2 binding to GAB1.
Buonato JM; Lan IS; Lazzara MJ
J Cell Sci; 2015 Nov; 128(21):3898-909. PubMed ID: 26359300
[TBL] [Abstract][Full Text] [Related]
2. EGFR-activated Src family kinases maintain GAB1-SHP2 complexes distal from EGFR.
Furcht CM; Buonato JM; Lazzara MJ
Sci Signal; 2015 May; 8(376):ra46. PubMed ID: 25969544
[TBL] [Abstract][Full Text] [Related]
3. Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor.
Meng S; Chen Z; Munoz-Antonia T; Wu J
Biochem J; 2005 Oct; 391(Pt 1):143-51. PubMed ID: 15952937
[TBL] [Abstract][Full Text] [Related]
4. SHP2 positively regulates TGFβ1-induced epithelial-mesenchymal transition modulated by its novel interacting protein Hook1.
Li S; Wang L; Zhao Q; Liu Y; He L; Xu Q; Sun X; Teng L; Cheng H; Ke Y
J Biol Chem; 2014 Dec; 289(49):34152-60. PubMed ID: 25331952
[TBL] [Abstract][Full Text] [Related]
5. Specific N-glycan alterations are coupled in epithelial-mesenchymal transition induced by EGF in GE11 epithelial cells.
Xu Q; Qu C; Wang W; Gu J; Du Y; Song L
Cell Biol Int; 2017 Feb; 41(2):124-133. PubMed ID: 27888538
[TBL] [Abstract][Full Text] [Related]
6. Enhanced EGF receptor-signaling potentiates TGFβ-induced lens epithelial-mesenchymal transition.
Shu DY; Lovicu FJ
Exp Eye Res; 2019 Aug; 185():107693. PubMed ID: 31201806
[TBL] [Abstract][Full Text] [Related]
7. Diminished functional role and altered localization of SHP2 in non-small cell lung cancer cells with EGFR-activating mutations.
Furcht CM; Muñoz Rojas AR; Nihalani D; Lazzara MJ
Oncogene; 2013 May; 32(18):2346-55, 2355.e1-10. PubMed ID: 22777356
[TBL] [Abstract][Full Text] [Related]
8. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.
Cunnick JM; Mei L; Doupnik CA; Wu J
J Biol Chem; 2001 Jun; 276(26):24380-7. PubMed ID: 11323411
[TBL] [Abstract][Full Text] [Related]
9. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
11. Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells.
Sun X; Zhang J; Wang Z; Ji W; Tian R; Zhang F; Niu R
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208810
[TBL] [Abstract][Full Text] [Related]
12. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.
Zhang K; Zhao H; Ji Z; Zhang C; Zhou P; Wang L; Chen Q; Wang J; Zhang P; Chen Z; Zhu HH; Gao WQ
Oncogene; 2016 Mar; 35(10):1271-82. PubMed ID: 26050620
[TBL] [Abstract][Full Text] [Related]
13. TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells.
Xu Z; Jiang Y; Steed H; Davidge S; Fu Y
Biochem Biophys Res Commun; 2010 Oct; 401(3):376-81. PubMed ID: 20854793
[TBL] [Abstract][Full Text] [Related]
14. EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells.
Muthusami S; Prabakaran DS; Yu JR; Park WY
Cancer Lett; 2014 Sep; 351(2):252-9. PubMed ID: 24971934
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
[TBL] [Abstract][Full Text] [Related]
16. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor.
Chen L; Sung SS; Yip ML; Lawrence HR; Ren Y; Guida WC; Sebti SM; Lawrence NJ; Wu J
Mol Pharmacol; 2006 Aug; 70(2):562-70. PubMed ID: 16717135
[TBL] [Abstract][Full Text] [Related]
18. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
[TBL] [Abstract][Full Text] [Related]
19. Identification of demethylincisterol A
Chen C; Liang F; Chen B; Sun Z; Xue T; Yang R; Luo D
Eur J Pharmacol; 2017 Jan; 795():124-133. PubMed ID: 27939989
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of TGFβ-induced lens epithelial to mesenchymal transition (EMT) by RTK antagonists.
Zhao G; Wojciechowski MC; Jee S; Boros J; McAvoy JW; Lovicu FJ
Exp Eye Res; 2015 Mar; 132():9-16. PubMed ID: 25576668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
